News
GT-02287 oral presentation demonstrates new evidence of disease-modifying capacity in GBA1 and idiopathic Parkinson's disease ...
Rocket Pharmaceuticals' gene therapies offer long-term effects for cardiovascular and hematology diseases. Read why I rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback